欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
SE/H/0961/002
药品名称
Oxytocin Grindeks
活性成分
oxytocin 16.7 µg/ml
剂型
solution for injection or infusion
上市许可持有人
AS GRINDEKS Latvia
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Austria (AT)
Belgium (BE)
Oxytocin Grindeks 10 IU/ml solution injectable/pour perfusion
Germany (DE)
OFOST 10 IU/ml Injektions-/Infusionslösung
France (FR)
Hungary (HU)
OXYTOCIN GRINDEKS 5 NE/ml oldatos injekció vagy infúzió
Ireland (IE)
Italy (IT)
Lithuania (LT)
Poland (PL)
Oxytocin Grindeks
Romania (RO)
OFOST 10 IU/ml soluţie injectabilă/perfuzabilă
Slovenia (SI)
Spain (ES)
Portugal (PT)
Slovakia (SK)
Latvia (LV)
Ofost 10 SV/ml šķīdums injekcijām/infūzijām
许可日期
2010/09/07
最近更新日期
2024/01/30
药物ATC编码
H01BB02 oxytocin
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final PL
|
SE_H_0961_002_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0961_002_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_0961_002_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_0961_002_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase